APA

Carrascosa A., Audí L., Fernández-Cancio M., Esteban C., Andaluz P., Vilaró E., Clemente M., Yeste D., Albisu M. A. & Gussinyé M. (20080415). The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age. : The Journal of clinical endocrinology and metabolism.

Chicago

Carrascosa A, Audí L, Fernández-Cancio M, Esteban C, Andaluz P, Vilaró E, Clemente M, Yeste D, Albisu M A and Gussinyé M. 20080415. The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age. : The Journal of clinical endocrinology and metabolism.

Harvard

Carrascosa A., Audí L., Fernández-Cancio M., Esteban C., Andaluz P., Vilaró E., Clemente M., Yeste D., Albisu M. A. and Gussinyé M. (20080415). The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age. : The Journal of clinical endocrinology and metabolism.

MLA

Carrascosa A, Audí L, Fernández-Cancio M, Esteban C, Andaluz P, Vilaró E, Clemente M, Yeste D, Albisu M A and Gussinyé M. The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age. : The Journal of clinical endocrinology and metabolism. 20080415.